J Over

752 total citations
28 papers, 584 citations indexed

About

J Over is a scholar working on Hematology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, J Over has authored 28 papers receiving a total of 584 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 9 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in J Over's work include Hemophilia Treatment and Research (16 papers), Protein purification and stability (6 papers) and Blood Coagulation and Thrombosis Mechanisms (6 papers). J Over is often cited by papers focused on Hemophilia Treatment and Research (16 papers), Protein purification and stability (6 papers) and Blood Coagulation and Thrombosis Mechanisms (6 papers). J Over collaborates with scholars based in Netherlands and United Kingdom. J Over's co-authors include Riek A. A. Vlooswijk, J J Sixma, JJ Sixma, Nel H. BEESER‐VISSER, Bonno N. Bouma, Hanneke Schuitemaker, F. A. C. van Engelenburg, Sixma Jj, M Tersmette and Harry Hiemstra and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Chromatography A and Thrombosis and Haemostasis.

In The Last Decade

J Over

27 papers receiving 513 citations

Peers

J Over

HEMAT

GENET

PRM

GENET

Rolf Ljung Sweden

G Torlontano Italy

D Samson United Kingdom

HA Perkins United States

Gerard J. Ventura United States

Colin Brown United Kingdom

R. Stamps United Kingdom

D.J. Booker United Kingdom

A. Insunza Spain

Michiko Takenaka Japan

Rolf Ljung Sweden

J Over

302 ×0.8

HEMAT

69 ×0.6

GENET

92 ×1.0

23 ×0.3

PRM

59 ×1.0

GENET

Citations per year, relative to J Over J Over (= 1×) peers Rolf Ljung

Countries citing papers authored by J Over

Since Specialization

Citations

This map shows the geographic impact of J Over's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Over with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Over more than expected).

Fields of papers citing papers by J Over

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Over. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Over. The network helps show where J Over may publish in the future.

Co-authorship network of co-authors of J Over

This figure shows the co-authorship network connecting the top 25 collaborators of J Over. A scholar is included among the top collaborators of J Over based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Over. J Over is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brummelhuis, H. G. J. & J Over. (2015). Virus Inactivation by Addition of Neutralizing Antibodies. Current studies in hematology and blood transfusion. 128–137.

Over, J, et al.. (2013). Viral Safety of Human Plasma–Derived Medicinal Products: Impact of Regulation Requirements. Transfusion Medicine Reviews. 27(3). 179–183. 15 indexed citations

Koenderman, Anky H. L., et al.. (2012). Virus safety of plasma products using 20 nm instead of 15 nm filtration as virus removing step. Biologicals. 40(6). 473–481. 11 indexed citations

Janssen, Mart P., J Over, C.L. van der Poel, H. Theo M. Cuijpers, & Ben A. van Hout. (2007). A probabilistic model for analyzing viral risks of plasma‐derived medicinal products. Transfusion. 48(1). 153–162. 10 indexed citations

Terpstra, Fokke G., Miranda Kleijn, Anky H. L. Koenderman, et al.. (2006). Viral safety of C1-inhibitor NF. Biologicals. 35(3). 173–181. 33 indexed citations

Bos, Octaaf J.M., et al.. (1998). Virus Validation of PH 4-treated Human Immunoglobulin Produced by the Cohn Fractionation Process. Biologicals. 26(4). 267–276. 32 indexed citations

Hiemstra, Harry, et al.. (1991). Inactivation of human immunodeficiency virus by gamma radiation and its effect on plasma and coagulation factors. Transfusion. 31(1). 32–39. 46 indexed citations

Beugeling, T., et al.. (1990). Large-scale purification of factor VIII by affinity chromatography: optimization of process parameters. Journal of Chromatography A. 503(1). 103–114. 10 indexed citations

Hiemstra, Harry, M Tersmette, Paul Strengers, et al.. (1990). Evaluation of wet pasteurization of a factor VIII concentrate produced by controlled-pore silica adsorption.. PubMed. 117(4). 557–63. 4 indexed citations

10.

Over, J, et al.. (1989). Affinity Purification of Plasma Proteins: Characterization of Six Affinity Matrices and their Application for the Isolation of Human Factor VIII. Thrombosis and Haemostasis. 61(2). 234–237. 6 indexed citations

11.

Goede, R. E. Y. de, et al.. (1986). Thermal Inactivation of Human Immunodeficiency Virus in Lyophilised Blood Products Evaluated by ID₅₀ Titrations. Vox Sanguinis. 51(3). 239–243. 16 indexed citations

12.

Brummelhuis, H. G. J., et al.. (1983). Contributions to the Optimal Use of Human Blood. Vox Sanguinis. 45(3). 205–216. 14 indexed citations

13.

Hellings, J.A., et al.. (1982). Immunoradiometric assay of VIII:CAg, a potential tool to detect human anti-VIII:C antibodies. Thrombosis Research. 26(4). 297–302. 4 indexed citations

14.

Over, J, J J Sixma, Barend Bouma, et al.. (1981). Survival of iodine-125-labeled factor VIII in patients with von Willebrand's disease.. PubMed. 97(3). 332–44. 28 indexed citations

15.

Sixma, JJ, et al.. (1978). Heterogeneity of human factor VIII. II. Characterization of forms of factor VIII binding to platelets in the presence of ristocetin.. PubMed. 92(1). 96–107. 73 indexed citations

16.

Over, J, et al.. (1978). Heterogeneity of human factor VIII. I. Characterization of factor VIII present in the supernatant of cryoprecipitate.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 91(1). 32–46. 42 indexed citations

17.

Akkerman, J W N, Gertie Gorter, S. de Graaf, et al.. (1978). Evaluation of Platelet Tests for Measurement of Cell Integrity. Thrombosis and Haemostasis. 39(1). 146–157. 20 indexed citations

18.

Sixma, Jan J., J Over, Bonno N. Bouma, A. L. Bloom, & I. R. Peake. (1978). Predominance of normal low molecular weight forms of factor VIII in “variant” von Willebrand's disease. Thrombosis Research. 12(5). 929–935. 15 indexed citations

19.

Over, J, et al.. (1977). Survival of Radiolabelled Human Factor VIII in Vivo. Thrombosis and Haemostasis. 3 indexed citations

20.

Akkerman, Jan Willem N., Gertie Gorter, J Over, Jan J. Sixma, & G.E.J. Staal. (1975). Human platelet 6-phosphofructokinase. Biochimica et Biophysica Acta (BBA) - Enzymology. 397(2). 395–404. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact